<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35277374</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Molecular analysis of Coxsackievirus A24 variant isolates from three outbreaks of acute hemorrhagic conjunctivitis in 1988, 1994 and 2007 in Beijing, China.</ArticleTitle><Pagination><StartPage>168</StartPage><EndPage>176</EndPage><MedlinePgn>168-176</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virs.2022.01.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1995-820X(22)00024-4</ELocationID><Abstract><AbstractText>Coxsackievirus A24 variant (CVA24v) is a major pathogen that causes continued outbreaks and pandemics of acute hemorrhagic conjunctivitis (AHC). In China, the first confirmed outbreak of CVA24v-related AHC occurred in Beijing in 1988, followed by another two significant outbreaks respectively in 1994 and 2007, which coincides with the three-stage dynamic distribution of AHC in the world after 1970s. To illustrate the genetic characteristics of CVA24v in different periods, a total of 23 strains were isolated from those three outbreaks and the whole genome of those isolations were sequenced and analyzed. Compared with the prototype strain, the 23 strains shared four nucleotide deletions in the 5' UTR except the 0744 strain isolated in 2007. And at the 98th site, one nucleotide insertion was found in all the strains collected from 2007. From 1994 to 2007, amino acid polarity in the VP1 region at the 25th and the 32nd site were changed. Both the 3C and VP1 phylogenetic tree indicated that isolates from 1988 and 1994 belonged to Genotype III (GIII), and 2007 strains to Genotype IV (GIV). According to the Bayesian analysis based on complete genome sequence, the most recent common ancestors for the isolates in 1988, 1994 and 2007 were respectively estimated around October 1987, February 1993 and December 2004. The evolutionary rate of the CVA24v was estimated to be 7.45 ​× ​10<sup>-3</sup> substitutions/site/year. Our study indicated that the early epidemic of CVA24v in Chinese mainland was the GIII. Point mutations and amino acid changes in different genotypes of CVA24v may generate intensity differences of the AHC outbreak. CVA24v has been evolving constantly with a relatively rapid rate.</AbstractText><CopyrightInformation>Copyright © 2022 The Authors. Publishing services by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Junhan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China; Nanguan District Center for Disease Control and Prevention, Changchun, 130042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Beijing Center for Disease Control and Prevention, Beijing, 100000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China; Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Tianjiao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Shuangli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dongyan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Zhenzhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jinbo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Fenfen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>National Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wenbo</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China; Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Dongmei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. Electronic address: dongmeiyan1976@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009711">Nucleotides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068476" MajorTopicYN="N" Type="Geographic">Beijing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003232" MajorTopicYN="Y">Conjunctivitis, Acute Hemorrhagic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030015" MajorTopicYN="Y">Enterovirus C, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009711" MajorTopicYN="N">Nucleotides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute hemorrhagic conjunctivitis (AHC)</Keyword><Keyword MajorTopicYN="N">Complete genome sequence</Keyword><Keyword MajorTopicYN="N">Coxsackievirus A24 variant (CVA24v)</Keyword><Keyword MajorTopicYN="N">Phylogenetic analysis</Keyword></KeywordList><CoiStatement>Conflicts of interest The authors declare that there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>12</Day><Hour>5</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35277374</ArticleId><ArticleId IdType="pmc">PMC9170931</ArticleId><ArticleId IdType="doi">10.1016/j.virs.2022.01.024</ArticleId><ArticleId IdType="pii">S1995-820X(22)00024-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Burr S.E., Sillah A., Joof H., Bailey R.L., Holland M.J. An outbreak of acute haemorrhagic conjunctivitis associated with coxsackievirus A24 variant in the Gambia, West Africa. BMC Res. Notes. 2017;10:692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5717804</ArticleId><ArticleId IdType="pubmed">29208044</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang W.K., Liu K.C., Foo T.C., Lam M.W., Chan C.F. Acute haemorrhagic conjunctivitis in Hong Kong 1971-1975. Southeast Asian J. Trop. Med. Publ. Health. 1977;8:1–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">196351</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopher S., Theogaraj S., Godbole S., John T.J. An epidemic of acute hemorrhagic conjunctivitis due to coxsackievirus A24. J. Infect. Dis. 1982;146:16–19.</Citation><ArticleIdList><ArticleId IdType="pubmed">6282991</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu P.Y., Ke G.M., Chang C.H., Lin J.C., Sun C.Y., Huang W.L., Tsai Y.C., Ke L.Y., Lin K.H. Molecular epidemiology of coxsackie A type 24 variant in Taiwan, 2000-2007. J. Clin. Virol. 2009;45:285–291.</Citation><ArticleIdList><ArticleId IdType="pubmed">19473877</ArticleId></ArticleIdList></Reference><Reference><Citation>Darriba D., Taboada G.L., Doallo R., Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nat. Methods. 2012;9:772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4594756</ArticleId><ArticleId IdType="pubmed">22847109</ArticleId></ArticleIdList></Reference><Reference><Citation>De W., Huanying Z., Hui L., Corina M., Xue G., Leng L., Hanri Z., Ling F., Yanling M., Huiqiong Z., Huan Z., Jing K., Caiyun L., Yoshida H., Changwen K. Phylogenetic and molecular characterization of coxsackievirus A24 variant isolates from a 2010 acute hemorrhagic conjunctivitis outbreak in Guangdong, China. Virol. J. 2012;9:41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3305440</ArticleId><ArticleId IdType="pubmed">22336176</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding L.X., Zhang Y., Li J., Dou X.F., Yan D.M., Zhu S.L., An H.Q., Xu W.B. Outbreak of acute hemorrhagic conjunctivitis in Beijing City in 2007 caused by coxsackievirus A24 variant: molecular identification and phylogenetic analysis. Bingdu Xuebao. 2009;25:251–256. (In Chinese)</Citation><ArticleIdList><ArticleId IdType="pubmed">19769156</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond A.J., Suchard M.A., Xie D., Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol. Biol. Evol. 2012;29:1969–1973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3408070</ArticleId><ArticleId IdType="pubmed">22367748</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca M.C., Pupo-Meriño M., García-González L.A., Resik S., Hung L.H., Muné M., Rodríguez H., Morier L., Norder H., Sarmiento L. Molecular evolution of coxsackievirus A24v in Cuba over 23-years, 1986-2009. Sci. Rep. 2020;10:13761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427094</ArticleId><ArticleId IdType="pubmed">32792520</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca M.C., Sarmiento L., Resik S., Pereda N., Rodríguez H., Kourí V., Martínez P.A., Piñón A., Limonta D., Más P., Hung L.H. Isolation of Coxsackievirus A24 variant from patients with hemorrhagic conjunctivitis in Cuba, 2008-2009. J. Clin. Virol. 2012;53:77–81.</Citation><ArticleIdList><ArticleId IdType="pubmed">22074932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiko H., Takeda N., Miyamura K., Kato N., Tanimura M., Lin K.H., Yin-Murphy M., Tam J.S., Mu G.F., Yamazaki S. Phylogenetic analysis of a coxsackievirus A24 variant: the most recent worldwide pandemic was caused by progenies of a virus prevalent around 1981. Virology. 1992;187:748–759.</Citation><ArticleIdList><ArticleId IdType="pubmed">1312276</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Stecher G., Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 2016;33:1870–1874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8210823</ArticleId><ArticleId IdType="pubmed">27004904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lévêque N., Amine I.L., Cartet G., Hammani A.B., Khazraji Y.C., Lina B., Muyembe J.J., Norder H., Chomel J.J. Two outbreaks of acute hemorrhagic conjunctivitis in Africa due to genotype III coxsackievirus A24 variant. Eur. J. Clin. Microbiol. Infect. Dis. 2007;26:199–202.</Citation><ArticleIdList><ArticleId IdType="pubmed">17294159</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Lv D., Zhang D., Sun X., Wang C., Zheng Z., Xu J., Dai K., Zhou Y., Tai Q. Health and disease prevention countermeasures and implementation of the 11th Asian Games. Zhong Guo Gong Gong Wei Sheng. 1993;9:147–149. (In Chinese)</Citation></Reference><Reference><Citation>Li H., Xu C., Yan J., Lu Y., Jin Q., Feng Y., Mo S. Study on the complete sequence of CA24 variant isolated during the acute hemorrhagic conjunctivitis outbreaks in Zhejiang province during 2002 to 2010. Zhonghua Liuxingbingxue Zazhi. 2013;34:496–502. (In Chinese)</Citation><ArticleIdList><ArticleId IdType="pubmed">24016443</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim K.H., Yin-Murphy M. An epidemic of conjunctivitis in Singapore in 1970. Singap. Med. J. 1971;12:247–249.</Citation><ArticleIdList><ArticleId IdType="pubmed">5134044</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.Y., Shih S.R., Pan M., Li C., Lue C.F., Stollar V., Li M.L. hnRNP A1 interacts with the 5' untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J. Virol. 2009;83:6106–6114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2687368</ArticleId><ArticleId IdType="pubmed">19339352</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng R., Qiu Y., Yan L., Kong Q., Liu G., Zhang S., Yang X. Study on etiology of acute hemorrhagic conjunctivitis in Qingdao during 1997. Zhonghua Shi yan He Lin Chuang Bing Du Xue Za Zhi = Chinese Journal of Experimental and Clinical Virology. 1999;13:86–87. (In Chinese)</Citation><ArticleIdList><ArticleId IdType="pubmed">12569792</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamura K., Yamashita K., Takeda N., Ogino T., Utagawa E., Yamazaki S., Fukumura K., Uehara T., Shinjo N. The first epidemic of acute hemorrhagic conjunctivitis due to a coxsackievirus A24 variant in Okinawa, Japan, in 1985-1986. Jpn. J. Med. Sci. Biol. 1988;41:159–174.</Citation><ArticleIdList><ArticleId IdType="pubmed">2855085</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu G., Lv H., Xu R., Li L., Gu Y., Lin G., Chen M. An etiology study on the 1986 epidemic of acute hemorrhagic conjunctivitis in China. Zhonghua Yufang Yixue Zazhi. 1992;26:174–175. (In Chinese)</Citation><ArticleIdList><ArticleId IdType="pubmed">1327682</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu G.F., Lv H., Xu R.L., Gu F.Z., Tan K., Pang G.X., Wei J.Y., Zhong Hua, Yu Fang, Yi Xue, Za Zhi. Vol. 24. 1990. pp. 129–131. (Etiology of 1988 Epidemic of Acute Hemorrhagic Conjunctivitis in Beijing). (In Chinese)</Citation><ArticleIdList><ArticleId IdType="pubmed">2174765</ArticleId></ArticleIdList></Reference><Reference><Citation>Nidaira M., Kuba Y., Saitoh M., Taira K., Maeshiro N., Mahoe Y., Kyan H., Takara T., Okano S., Kudaka J., Yoshida H., Oishi K., Kimura H. Molecular evolution of VP3, VP1, 3C(pro) and 3D(pol) coding regions in coxsackievirus group A type 24 variant isolates from acute hemorrhagic conjunctivitis in 2011 in Okinawa. Japan. Microbiol. Immunol. 2014;58:227–238.</Citation><ArticleIdList><ArticleId IdType="pubmed">24517637</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut A., Drummond A.J., Xie D., Baele G., Suchard M.A. Posterior summarization in bayesian phylogenetics using tracer 1.7. Syst. Biol. 2018;67:901–904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6101584</ArticleId><ArticleId IdType="pubmed">29718447</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawyer L.A., Hershow R.C., Pallansch M.A., Fishbein D.B., Pinsky P.F., Broerman S.F., Grimm B.B., Anderson L.J., Hall D.B., Schonberger L.B. An epidemic of acute hemorrhagic conjunctivitis in American Samoa caused by coxsackievirus A24 variant. Am. J. Epidemiol. 1989;130:1187–1198.</Citation><ArticleIdList><ArticleId IdType="pubmed">2556026</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., He X. Epidemic Trend analysis of acute hemorrhagic conjunctivitis in Beijing from 1991 to 1998. Ji Bing Jian Ce. 1999;14:421–422. (In Chinese)</Citation></Reference><Reference><Citation>Tavares F.N., Costa E.V., Oliveira S.S., Nicolai C.C., Baran M., da Silva E.E. Acute hemorrhagic conjunctivitis and coxsackievirus A24v, Rio de Janeiro, Brazil, 2004. Emerg. Infect. Dis. 2006;12:495–497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3291458</ArticleId><ArticleId IdType="pubmed">16704792</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zhao J., Zhang S. Analysis of epidemic characteristics and cause of outbreak of acute hemorrhagic conjunctivitis in China. Ji Bing Jian Ce. 2014;29:92–97. (In Chinese)</Citation></Reference><Reference><Citation>Yan D., Zhu S., Zhang Y., Zhang J., Zhou Y., Xu W. Outbreak of acute hemorrhagic conjunctivitis in Yunnan, People's Republic of China, 2007. Virol. J. 2010;7:138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2901270</ArticleId><ArticleId IdType="pubmed">20579343</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen Y.C., Chu P.H., Lu P.L., Lin Y.C., Shi Y.Y., Chou L.C., Wang C.F., Lin Y.Y., Su H.J., Lin C.C., Zeng J.Y., Tyan Y.C., Ke G.M., Chu P.Y. Phylodynamic characterization of an ocular-tropism coxsackievirus A24 variant. PLoS One. 2016;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987047</ArticleId><ArticleId IdType="pubmed">27529556</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>